The Manufacturers Life Insurance Company Has $2 Million Position in National Health Investors, Inc. (NYSE:NHI)

The Manufacturers Life Insurance Company lessened its stake in National Health Investors, Inc. (NYSE:NHI) by 1.1% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,777 shares of the real estate investment trust’s stock after selling 274 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.05% of National Health Investors worth $1,999,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Covestor Ltd grew its holdings in National Health Investors by 2,700.0% during the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 405 shares during the period. Loomis Sayles & Co. L P purchased a new stake in shares of National Health Investors during the third quarter worth $38,000. International Assets Investment Management LLC bought a new position in shares of National Health Investors in the second quarter worth $36,000. Assetmark Inc. grew its position in shares of National Health Investors by 27.8% in the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 141 shares in the last quarter. Finally, Blue Trust Inc. raised its stake in shares of National Health Investors by 2,651.9% during the 2nd quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 716 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Price Performance

NHI opened at $74.35 on Tuesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. National Health Investors, Inc. has a 1 year low of $51.59 and a 1 year high of $86.13. The stock’s 50 day simple moving average is $77.73 and its 200 day simple moving average is $75.29. The firm has a market cap of $3.38 billion, a price-to-earnings ratio of 25.55, a PEG ratio of 5.05 and a beta of 1.04.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The firm had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. National Health Investors’s revenue was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.08 EPS. As a group, analysts predict that National Health Investors, Inc. will post 4.42 earnings per share for the current year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.84%. National Health Investors’s dividend payout ratio is presently 123.71%.

Analyst Upgrades and Downgrades

NHI has been the topic of a number of recent analyst reports. Wells Fargo & Company downgraded shares of National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Truist Financial increased their target price on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Finally, Bank of America initiated coverage on National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, National Health Investors has an average rating of “Moderate Buy” and a consensus price target of $76.33.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.